These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12667430)

  • 1. Applied gene therapy in preclinical models of vascular injury.
    Janssens SP
    Curr Atheroscler Rep; 2003 May; 5(3):186-90. PubMed ID: 12667430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy.
    Channon KM; Qian H; George SE
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1873-81. PubMed ID: 10938006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adventitial gene transfer to arterial wall.
    Laitinen M; Ylä-Herttuala S
    Pharmacol Res; 1998 Apr; 37(4):251-4. PubMed ID: 9634639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis.
    French BA; Mazur W; Ali NM; Geske RS; Finnigan JP; Rodgers GP; Roberts R; Raizner AE
    Circulation; 1994 Nov; 90(5):2402-13. PubMed ID: 7955199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adenoviral titer and instillation pressure on gene transfer efficiency to arterial and venous grafts ex-vivo.
    Brevetti LS; Chang DS; Sarkar R; Messina LM
    J Vasc Surg; 2002 Aug; 36(2):263-70. PubMed ID: 12170198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for arterial thrombosis.
    Vassalli G; Dichek DA
    Cardiovasc Res; 1997 Sep; 35(3):459-69. PubMed ID: 9415290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular gene transfer.
    Ylä-Herttuala S
    Curr Opin Lipidol; 1997 Apr; 8(2):72-6. PubMed ID: 9183544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for vascular disease.
    Finkel T; Epstein SE
    FASEB J; 1995 Jul; 9(10):843-51. PubMed ID: 7615154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for vascular diseases.
    Nabel EG
    Atherosclerosis; 1995 Dec; 118 Suppl():S51-6. PubMed ID: 8821465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels.
    Channon KM; Fulton GJ; Gray JL; Annex BH; Shetty GA; Blazing MA; Peters KG; Hagen PO; George SE
    Cardiovasc Res; 1997 Sep; 35(3):505-13. PubMed ID: 9415295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production.
    West NE; Qian H; Guzik TJ; Black E; Cai S; George SE; Channon KM
    Circulation; 2001 Sep; 104(13):1526-32. PubMed ID: 11571247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets for gene therapy of vein grafts.
    Newby AC; Baker AH
    Curr Opin Cardiol; 1999 Nov; 14(6):489-94. PubMed ID: 10579065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular gene transfer for the treatment of restenosis and atherosclerosis.
    Laitinen M; Ylä-Herttuala S
    Curr Opin Lipidol; 1998 Oct; 9(5):465-9. PubMed ID: 9812201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
    von der Leyen HE; Gibbons GH; Morishita R; Lewis NP; Zhang L; Nakajima M; Kaneda Y; Cooke JP; Dzau VJ
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1137-41. PubMed ID: 7532305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for cardiovascular disease: a case for cautious optimism.
    Khurana R; Martin JF; Zachary I
    Hypertension; 2001 Nov; 38(5):1210-6. PubMed ID: 11711525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer to the vascular system: Novel translational perspectives for vascular diseases.
    Remes A; Basha DI; Frey N; Wagner AH; Müller OJ
    Biochem Pharmacol; 2020 Dec; 182():114265. PubMed ID: 33035508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo.
    Shears LL; Kibbe MR; Murdock AD; Billiar TR; Lizonova A; Kovesdi I; Watkins SC; Tzeng E
    J Am Coll Surg; 1998 Sep; 187(3):295-306. PubMed ID: 9740187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts.
    Chen SJ; Wilson JM; Muller DW
    Circulation; 1994 May; 89(5):1922-8. PubMed ID: 7514108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
    Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
    Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.
    Walter DH; Cejna M; Diaz-Sandoval L; Willis S; Kirkwood L; Stratford PW; Tietz AB; Kirchmair R; Silver M; Curry C; Wecker A; Yoon YS; Heidenreich R; Hanley A; Kearney M; Tio FO; Kuenzler P; Isner JM; Losordo DW
    Circulation; 2004 Jul; 110(1):36-45. PubMed ID: 15210598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.